Naturally occurring antinociceptive substances from plants

Phytotherapy Research

Volumn 14, Issue 6, 2000, Pages 401-418

  Calixto, Joo B ^a   Beirith, Alessandra ^a   Ferreira, Juliano ^a   Santos, Adair R S ^a,b   Filho, Valdir Cechinel ^b   Yunes, Rosendo A ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

Author keywords

Alkaloids; Antinociceptive; Cannabis sativa; Capsicum; Flavonoids; Papaver somniferum; Terpenoids

Indexed keywords

ACETYLSALICYLIC ACID; ACONITINE; ACONITUM EXTRACT; ALKALOID DERIVATIVE; CAFFEINE; CANNABINOID; CANNABIS; CAPSAICIN DERIVATIVE; CAPSICUM EXTRACT; CODEINE; DIAMORPHINE; FLAVONOID; GINSENG EXTRACT; GLYCOSIDE; METHADONE; MITRAGYNINE; MORPHINE; MYRCENE; NALORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLANT EXTRACT; POLYGODIAL; SALIX EXTRACT; SESQUITERPENE LACTONE; STEROID; TERPENOID DERIVATIVE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIC ACTIVITY; ANTINOCICEPTION; CONSTIPATION; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; NOCICEPTION; NONHUMAN; PAPAVER SOMNIFERUM; REVIEW; SEDATION; STRUCTURE ACTIVITY RELATION;

ANALGESICS; CANNABIS; CAPSICUM; HUMANS; PAIN, INTRACTABLE; PAPAVER; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; SALIX; STRUCTURE-ACTIVITY RELATIONSHIP;

ACONITUM; CANNABIS; CANNABIS SATIVA; CAPSICUM; PANAX GINSENG; PAPAVER SOMNIFERUM; SALIX;

EID: 0033817918     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1573(200009)14:6<401::AID-PTR762>3.0.CO;2-H     Document Type: Review

References (221)

1. Effects of naloxone, glycyrrhizic acid, dexamethasone and deoxycorticosterone in repetitive stress
2. Effects of Psychotria colorata alkaloids in brain opioid system
3. Mechanisms underlying the relaxation caused by the sesquiterpene polygodial in vessels from rabbit and guinea-pig
4. Nepetalactone: A new opioid analgesic from Nepeta casearea Boiss
5. Analgesic activity of Nepeta italica L.
6. Pot, heroin unlock new areas for neuroscience
7. The development of cannabinoid antagonists
8. Study of the antinociceptive action of the ethanolic extract and the triterpene 24-hydroxytormentic acid isolated from the stem bark of Ocotea suaveolens
9. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain
10. Morphine: New aspects in the study of an ancient compound
11. The neurobiology of pain
12. Peripheral and spinal mechanisms of nociception
13. Antinociceptive activity of 13,118-binaringenin, a biflavonoid present in plants of the family Guttiferae
14. Chemical and pharmacological examination of Wedelia paludosa
15. Phytochemical and pharmacological analysis of different parts of Wedelia paludosa DC (Compositae)
16. Hepatitis B virus and hepatocellular carcinoma-treatment of HBV carriers with Phyllanthus amarus
17. Analgesic effect of furanic labdane diterpenes from Marrubium vulgare L.
18. Revue des therapeutiques pharmacologiques actualles de la doleur
19. A brief history of opiates, opioid peptides, and opioid receptors
20. The effect of naloxone on adrenocorticotropin and cortisol release: Evidence for a reduced response in depression
21. Marijuana as a medicine
22. Control of pain initiation by endogenous cannabinoids
23. A review of the plants of the genus Phyllanthus: Their chemistry, pharmacology, and therapeutic potential
24. The analgesic activity of Hedyosmum bonplandianum: Flavonoid glycosides
25. Acute pain
26. Investigation of anti-inflammatory and antinociceptive activities of transdehydrocrotonin, a 19-nor-clerodane diterpene from Croton cajucara. Part 1
27. The mechanisms of action of NSAIDs in analgesia
28. Impaired nociception and pain sensation in mice lacking the capsaicin receptor
29. The capsaicin receptor: A heat-activated ion channel in the pain pathway
30. 2+-release by methylxanthine analogues
31. Isolation and identification of active compounds from Drimys winteri barks
32. Antinociceptive and anti-edematogenic effects of astilbin, taxifolin and related compounds
33. Chemical and pharmacological studies of Phyllanthus caroliniensis in mice
34. Molecular cloning and functional expression of a mu-opioid receptor from rat brain
35. Mechanism of analgesic action of hyperin
36. Opioid analgesics
37. Aspirin and related derivatives of salicylic acid
38. Adenosine receptor sub-types
39. Further characterization of morphine-like peptides (endorphins) from pituitary
40. Natural products in drug discovery and development
41. Analogues of caffeine and theophylline: Effect of structural alterations on affinity at adenosine receptors
42. Antinociceptive properties of the hydroalcoholic extract and preliminary study of xanthone isolated from Polygala cyparissias (Polygalaceae)
43. Analysis of the antinociceptive properties of marrubiin isolated from Marrubium vulgare
44. The role of plant-derived drugs and herbal medicines in healthcare
45. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
46. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence
47. International union of pharmacology. XII. Classification of opioid receptors
48. Methadone conformation and opioid activity
49. Action of the extract of Drimys winteri on contraction induced by inflammatory mediators, compound 48/80 and ovalbumin of the guinea-pig trachea in vitro
50. Action of polygodial, a sesquiterpene isolated from Drimys winteri, in the guinea-pig ileum and trachea in vitro
51. In vitro effect of the extract and the 1,7-dihydroxy-2,3-dimethoxy xanthone from Polygala cyparissias on the contraction induced by inflammatory mediators and ovalbumin in normal and activity sensitised trachea from guinea-pig
52. Action of polygodial on agonist-induced contractions of the rat portal vein in vitro
53. Analgesic activity of Psychotria colorata (Wild. ex R. and S.) Muell. Arg. Alkaloids
54. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests
55. Pharmacological evaluation of the anti-inflammatory activity of a citrus bioflavonoid, hesperidin, and the isoflavonoids, duartin and claussequinone, in rats and mice
56. Cloning of a delta opiod receptor by functional expression
57. Mast-cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamine
58. Antinociceptive properties of the methanolic extract and two triterpenes isolated from Epidendrum mosenii stems (Orchidaceae)
59. The role of systemic, spinal and supraspinal L-arginine-nitric oxide-cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice
60. Prostaglandins, aspirin-like drugs and analgesia
61. Watching the pot boil
62. Analgesic compounds from Epidendrum mosenii stems
63. The medicinal uses of Cannabis and its constituents
64. + channels, toxicity and antinociceptive properties
65. 2 synthase (cyclooxygenase) in human monocytes
66. Transmitters involved in antinociception in the spinal cord
67. Analgesic triterpenes from Sebastiania schottiana roots
68. Isolation, structure, and partial synthesis of an active constitutent of hashish
69. Porcine pituitary dynorphin: Complete amino acid sequence of the biologically active heptadecapeptide
70. Potent antinociceptive activity of the hydroalcoholic extract from Phyllanthus corcovadensis
71. Peripheral and central mechanisms of pain
72. Mode of antinociceptive and toxic action of alkaloids of Aconitum spec.
73. History of antipyretic analgesic therapy
74. Bioactivity in plants: The link between phytochemistry and medicine
75. Resinferatoxin and other esters of novel polyfunctional diterpenes from Euphorbia resinifera and unispina
76. Pharmacology and potential therapeutic uses of cannabis
77. Pain relief with oral cannabinoids in familial mediterranean fever
78. Capsaicin: Cellular targets, mechanisms of action, and selectivity for sensory neurons
79. Using artifical neural networks to classify the activity of capsaicin and its analogues
80. Pharmacology of cannabinoid receptors
81. The burning mouth syndrome
82. Identification of two related pentapeptides from the brain with potent opiate agonist activity
83. Desensitization of sensory nerve endings
84. Possible use of capsaicin in pain therapy
85. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel
86. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand
87. The delta-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterisation
88. Inhibition of rat adjuvant-induced arthritis by ginkgetin, a biflavone from Ginkgo biloba leaves
89. Amentoflavone, a plant biflavone: A new potential anti-inflammatory agent
90. 3 adenosine receptors
91. Quantitative structure-agonist activity relationship of capsaicin analogues
92. Ginkgo biloba extract and folic acid in the therapy of changes caused by autonomic neuropathy
93. The sympathetic nervous system and pain
94. Antinociceptive components of Ganoderma lucidum
95. Isolation and identification of compounds with antinociceptive action from Ipomoea pes-caprae (L.)R. Br.
96. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cell, encodes a novel prostaglandin synthase/cyclooxygenase homologue
97. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
98. Potential therapeutic usefulness of marijuana
99. Pain: An overview
100. Myrcene mimics the peripheral analgesic activity of lemongrass tea
101. Isolation of biflavonoids with analgesic activity from Rheedia gardneriana leaves
102. Capsaicin: Actions on nociceptive C-fibers and therapeutic potential
103. Triterpenes
104. Structural requirements for cannabinoids-induced antinociceptive activity in mice
105. Antinociceptive actions of cannabinoids following intraventricular administration in rats
106. A comparative study of the analgesic and anti-inflammatory activities of pectolinarin isolated from Cirsium subcoriaceum and linarin isolated from Buddleia cordata
107. Compounds extracted from Phyllanthus and Jatropha elliptica inhibit the binding of [3H]glutamate and [3H]GMP-PNP in rat cerebral cortex membrane
108. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice
109. Structure of cannabinoid receptor and functional expression of the cloned cDNA
110. Central antinociceptive effects of mitragynine in mice: Contribution of descending noradrenergic and serotonergic systems
111. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene
112. Phenyl-substituted normethadones: Synthesis and pharmacology
113. The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects
114. Marijuana chemistry
115. Pharmacotherapy of opioids: Present and future developments
116. Anti-hyperalgesic properties of the extract and of the main sesquiterpene polygodial isolated from the barks of Drymis winteri (Winteraceae)
117. Assessment of the mechanisms involved in the antinociception caused by sesquiterpene polygodial
118. An analgesic circuit activated by cannabinoids
119. Nociceptin/orphanin FG and the opioid receptor-like ORL1 receptor
120. Preliminary phytochemical and pharmacological studies of Aleurites moluccana leaves
121. Isolation of a C-glycoside flavonoid with antinociceptive action from Aleurites moluccana leaves
122. Purification of prostaglandin endoperoxide synthese from bovine vesicular gland microsomes
123. cis-8, 10-Di-n-propyllobelidiol hydrochloride dihydrate
124. Chemical and preliminary analgesic evaluation of geraniin and furosin isolated from Phyllanthus sellowianus
125. A triterpene and phenolic compounds from leaves and stems of Phyllanthus sellowianus
126. The induction of pain: An integrative review
127. Ginsenoside RF, a trace component of ginseng root, produces antinociception in mice
128. ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localisation
129. 4 inhibitors: New xanthine analogues
130. Synthesis and structure-activity relationships of 3,7-dimethylxanthine derivatives, A2A -selective adenosine receptor antagonists
131. Molecular characterization of a peripheral receptor for cannabinoids
132. Ginseng root extract inhibits calcium channels in rat sensory neurons through a similar path, but different receptor, as mu-type opioids
133. Acteoside as the analgesic principle of Cedron (Lippia truphylla), a Peruvian medicinal plant
134. The constitution of capsaicin.- The pungent principle of capsicum
135. Antinociceptive activity of Niga-ichigoside F (1) from Rubus imperialis
136. An overview of nonsteroidal antiinflammatory agents (NSAIA)
137. Cyclooxygenase-2: Molecular biology, pharmacology and neurobiology
138. On the preparation of Indian hemp or gunjah
139. Capsaicin activates a nonselective cation channel in cultured neonatal rat dorsal root ganglion neurons
140. Pharmacological studies of lappaconitina. Analgesic activities
141. The relaxant effect of extract of Phyllanthus urinaria on the guinea pig isolated trachea. Evidence for involvement of ATP-sensitive potassium channels
142. The mechanisms underlying the relaxant effect of methyl and ethyl gallates in the guinea pig trachea in vitro. Contribution of potassium channels
143. Analgesic compounds from Croton urucurana Baillon. Pharmaco-chemical criteria used in their isolation
144. Three xanthones from Polygala cyparissias
145. Cannabinoids endogenous ligands and synthetic analogs
146. Management of cancer pain
147. Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis
148. Antagonism of the acute pharmacological actions of morphine by Panax ginseng extract
149. Antinociceptive and anti-inflammatory activity of a flavonoid isolated from Caralluma attenuata
150. Antinociceptive and antipyretic effects of alkaloids extracted from the stem bark of Hunteria zeylanica
151. Antinociceptive effects of Randia siamensis extract and its constituent, pseudoginsenoside-RP1 in experimental animals
152. Inhibitory effect of alkaloids extracted from the stem bark of Hunteria zeylanica on 5-lipoxygenase activity in vitro
153. Orphanin FQ: A neuropeptide that activates an opioid like G protein-coupled receptor
154. Pharmacological activity of aporphinoid alkaloids. A review
155. Chronic pain
156. Anti-inflammatory actions of pentacyclic triterpenes
157. Further studies on the antinociceptive action of the hydroalcoholic extracts from plants of the genus Phyllanthus
158. Analysis of the mechanisms underlying the antinociceptive effect of the extracts of plants from the genus Phyllanthus
159. + channels and G(i/o) protein in the antinociceptive action of the gallic acid ethyl ester
160. Antinociceptive properties of the new alkaloid, cis-8, 10-Di-N-propyllobelidiol hydrochloride dihydrate isolated from Siphocampylus verticillatus: Evidence for the mechanism of action
161. Antinociceptive properties of steroids isolated from Phyllanthus corcovadensis in mice
162. Pharmacological rationale for the clinical use of caffeine
163. 2 receptors
164. Adenosine receptor activation and nociception
165. Structure and receptor activity for classical cannabinoids
166. Effects of 8-phanyl and 8-cycloalkyl substituents on the activity of mono-,di-, and tri-substituted alkylxanthines with substitution at the 1-,3-, and 7-positions
167. Ginsenosides that produce differential antinociception in mice
168. Recent natural products based drug development: A pharmaceutical industry perspective
169. Prostaglandin endoperoxide H synthases-1 and -2
170. Novel natural vanilloid receptor agonists: New therapeutic targets for drug development
171. Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2
172. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and β-endorphin in mice
173. Antinociceptive effect of smilaxin B administered intracerebroventricularly in the mouse
174. Mechanisms and therapeutic potential of vanilloids (capsaicin-like molecules)
175. The vanilloid (capsaicin) receptor: Receptor types and species differences
176. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man
177. Vanilloid (capsaicin) receptors and mechanisms
178. Comparative receptor binding analyses of cannabinoid agonists and antagonists
179. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice
180. Isolation of capsaicin
181. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus
182. From ethnobotanical uses of Strychnos henningsii to antiinflammatories, analgesic and antispasmodics
183. The cloned capsaicin receptor integrates multiple pain-producing stimuli
184. Anti-allergic effects and oedema inhibition caused by the extract of Drymis winteri
185. Antinociception caused by the extract of Hedyosmum brasiliense and its active principle, the sesquiterpene lactone 13-hydroxy-8,9-dehydroshizukanolide
186. Mechanisms involved in the antinociceptive effect in mice of the hydroalcoholic extract of Siphocampylus verticillatus
187. Capsazepine, a novel capsaicin antagonist, selectively antagonizes the effects of capsaicin in the mouse spinal cord in vitro
188. Central mechanisms in pain
189. Antinociceptive, antiinflammatory and antipyretic effects of lapidin, a bicyclic sesquiterpene
190. New insights into the mode of actions of anti-inflammatory drugs
191. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
192. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of nociception in mice
193. Analysis of 50 patients with atypical odontalgia. A preliminary report on pharmacological procedures for diagnosis and treatment
194. Gossypin-induced analgesia in mice
195. Analgesic activity of bacosine, a new triterpene isolated from Bacopa monnieri
196. The neurobiology of cannabinoid analgesia
197. NSAID: An update on their analgesic effects
198. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. A. The aromatic 'A-region'
199. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. B. The amide bond 'B-region'
200. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. C. The hydrophobic side-chain 'C-region'
201. Herbs of the genus Phyllanthus in the treatment of chronic hepatitis B: Observations with three preparations from different geographic sites
202. 9-THC-induced antinociception
203. Chemical activators of sensory neurons
204. Analogues of capsaicin with agonist activity as novel analgesic agents: Structure-activity studies
205. Kappa-opioid receptor-mediated antinociceptive effects of stereoisomers and derivatives of (+)-matrine in mice
206. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
207. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
208. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain
209. Ginsenosides induce differential antinociception and inhibit substance P induced-nociceptive response in mice